other material
confidence high
sentiment negative
materiality 0.30
Biofrontera announces voluntary recall of limited Ameluz® lots due to packaging defect
Biofrontera Inc.
- Licensor Biofrontera AG initiated voluntary recall of limited Ameluz® lots due to packaging manufacturing defect.
- Recalled product not likely to cause adverse health consequences per Licensor.
- Company notifying physician customers and arranging prompt replacement of recalled products.
- Company will not bear any financial responsibility for recall costs; no material financial impact anticipated.